MMR in the treatment of warts

A study in Egypt examined the efficacy and safety of using intralesional MMR vaccine to treat recalcitrant warts

Seventy men and women with multiple recalcitrant extragenital warts took part. Their largest wart was injected with 0.3 intralesional MMR vaccine every two weeks until clearance or until five injections had been given. Participants were followed up monthly for six months.

Of 65 patients completing the study, clearance was observed in 41 (63%), a partial response in 15 (23%) and no response in nine (14%). Only two patients experienced recurrence of the wart.

The researchers concluded that intralesional antigen immunotherapy using the MMR vaccine appears to be effective and safe and is therefore a promising treatment for patients with recalcitrant warts.

Nofal A, Nofal E, Yosef A et al. Int J Dermatol July 28 2014 doi: 10.1111/ijd.12480


Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Vitamin D3 Supplements

Formulations and indications of colecalciferol preparations.

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Avoid gout drug in patients with major cardiovascular conditions, says MHRA

Treatment with febuxostat (Adenuric) should be avoided...

Drug shortages - live tracker

Drug shortages - live tracker

Added: Colestid Orange. Use our constantly updated...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...